RL-208

N/A

Report date: 2025/01/26 18:02:01
NME

Base Information

Drug NameRL-208
Drug Alias NameNMDA channel blocker (Universitat de Barcelona)RL-208
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversitat De Barcelona
China Registration ClassN/A

Develop Information

Active CompaniesUniversitat De Barcelona
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A